LISA SARMASTI: Open Payments
NPI 1952172348 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$188 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $107 · 2025 $188
Food & beverage: $188
| Company | Payments | Amount |
|---|---|---|
| TAIHO ONCOLOGY, INC. | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Novocure Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Eisai Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
Products named: LONSURF, Vitrakvi, Stivarga, Optune Lua (NovoTTF-200T), Lenvima, EMRELIS.
Industry payments across NY — which companies pay providers there.
